OUR SCIENCE
Poster presentations
EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug developmentMarch 31, 2019
1:00-5:00PM | section 21
view poster abstract
Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
March 31, 2019
1:00-5:00PM | section 21
view poster abstract
EVT801: a selective VEGFR3 inhibitor with the potential for combination with immune-checkpoint therapies, preclinical evidences and plans for first-in-human evaluation
April 2, 2019
1:00-5:00PM | section 23
view poster abstract